The trajectory for most of our long-term initiatives is going to be a lot clearer by the end of this year,' said CEO Mark ...

Expensify stock is rated a sell due to high market growth expectations, significant seat churn, minimal revenue growth, and ...

Corporate America just kicked off a new quarterly earnings season. Over the next few weeks, hundreds of companies will report ...

Wall Street ended up on relief Meta and Microsoft kept their AI spending plans even amid mixed earnings. Next up, Apple earnings.

We recently published a list of 10 AI Stocks Analysts Are Focusing On These Days. In this article, we are going to take a ...

Sometimes the scorecard of the U.S. economy, known as GDP, tells the whole story. But not for the fourth quarter. The economy was stronger than it looked.

We recently published a list of Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks. In this article, we are going to take a look at where Broadcom Inc.

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are going to take a look at where Advanced Micro Devices, Inc.

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...

RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ:GCTK), a medical device company specializing in diabetes care technology, has ...